Denali Therapeutics Inc (NASDAQ:DNLI)
| 35.79 Delayed Data As of Aug 05 |  +2.39 / +7.16%Today’s Change | 20.24 Today|||52-Week Range 56.80 | -19.75% Year-to-Date |
Institutional investors purchased a net $2.4 million shares of DNLI during the quarter ended June 2019, and now own 69.00% of the total float, a percentage that is typical for companies in the Biotechnology industry.
| Individual stakeholders | 51.08% |
| Mutual fund holders | 41.53% |
| Other institutional | 27.48% |
Largest Quarterly Institutional
Transactions
Latest Institutional Activity
| 6/30/2022 | CANDRIAM BELGIUM SA Bought 181.4 Thousand shares of Denali Therapeutics Inc |
| 6/30/2022 | GLOBAL X MANAGEMENT CO. LLC Bought 32.1 Thousand shares of Denali Therapeutics Inc |
| 6/30/2022 | SG AMERICAS SECURITIES LLC Bought 30.3 Thousand shares of Denali Therapeutics Inc |
Top 10 Owners of Denali Therapeutics Inc
| Stockholder | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Baillie Gifford & Co. | 12.18% | 14,980,432 | 440,874,114 | -75,949 | -0.50% |
| The Vanguard Group, Inc. | 6.40% | 7,873,852 | 231,727,464 | -41,713 | -0.53% |
| Crestline Management LP | 6.07% | 7,460,732 | 219,569,343 | -244,307 | -3.17% |
| BlackRock Fund Advisors | 5.48% | 6,732,249 | 198,130,088 | +107,672 | +1.63% |
| Temasek Holdings Pte Ltd. (Invest... | 4.37% | 5,369,487 | 158,024,002 | 0 | 0.00% |
| T. Rowe Price Associates, Inc. (I... | 4.00% | 4,923,425 | 144,896,398 | +287,992 | +6.21% |
| SSgA Funds Management, Inc. | 3.11% | 3,826,792 | 112,622,489 | +799,221 | +26.40% |
| Fidelity Management & Research Co... | 2.39% | 2,937,574 | 86,452,803 | -7,895 | -0.27% |
| Gilder, Gagnon, Howe & Co. LLC | 2.13% | 2,619,217 | 77,083,556 | -280,897 | -9.69% |
| Credit Suisse Asset Management (S... | 1.57% | 1,934,660 | 56,937,044 | +11,864 | +0.62% |
Top 10 Mutual Funds Holding Denali Therapeutics Inc
| Mutual fund | Stake | Shares owned | Total value ($) | Shares bought / sold | Total change |
|---|---|---|---|---|---|
| Scottish Mortgage Investment Trus... | 5.01% | 6,153,707 | 181,103,597 | 0 | 0.00% |
| Vanguard US Growth Fund | 2.72% | 3,342,326 | 98,364,654 | 0 | 0.00% |
| Vanguard Total Stock Market Index... | 2.08% | 2,556,091 | 75,225,758 | +31,282 | +1.24% |
| iShares Russell 2000 ETF | 1.78% | 2,191,123 | 64,484,750 | -2,208 | -0.10% |
| Vanguard Small Cap Index Fund | 1.77% | 2,169,666 | 63,853,270 | +24,110 | +1.12% |
| SPDR S&P Biotech ETF | 1.56% | 1,914,284 | 56,337,378 | -45,408 | -2.32% |
| Baillie Gifford Overseas Growth F... | 1.55% | 1,904,836 | 56,059,323 | -48,418 | -2.48% |
| CS Invt. Fds. 2 - (Lux) Digital H... | 1.51% | 1,850,000 | 54,445,500 | 0 | 0.00% |
| T Rowe Price New Horizons Fund | 1.25% | 1,531,333 | 45,067,130 | -1,290 | -0.08% |
| T Rowe Price Health Sciences Fund | 1.07% | 1,318,485 | 38,803,014 | -148,246 | -10.11% |